厄贝沙坦联合雷米普利在风湿性心脏病慢性心力衰竭患者中的作用

被引：4

作者：

丁平 ^{[1
]}

李莉 ^{[1
]}

徐志云 ^{[1
]}

韩林 ^{[1
]}

何斌 ^{[1
]}

胡莹 ^{[2
]}

机构：

[1] 第二军医大学长海医院心胸外科

[2] 第二军医大学卫生勤务学系卫生统计学教研室

来源：

第二军医大学学报 | 2008年 / 06期

关键词：

厄见沙坦; 雷米普利; 慢性心力衰竭; 风湿性心脏病;

D O I：

暂无

中图分类号：

R541.61 []; R541.2 [风湿性心脏病];

学科分类号：

100201 [内科学];

摘要：

目的:观察厄贝沙坦联合雷米普利在风湿性心脏病慢性心力衰竭患者中的作用。方法:120例风心瓣膜置换术后慢性心力衰竭患者随机分为试验组(60例)和对照组(60例)。所有患者常规给予雷米普利5mg,1/d治疗,试验组加用厄贝沙坦150 mg,1/d。随访6个月.观察指标为心功能(纽约心脏协会,NYHA)分级、6min步行实验、超声心动图各参数。结果:治疗6个月后,试验组较对照组心功能分级、6min步行实验、超声心动图各项指标(左室舒张朱期内径、左室收缩末期内径、左室射血分数、短轴缩短率)均改善明显(P<0.05)。结论:厄贝沙坦联合雷米普利可显著改善风心慢性心力衰竭患者心功能、逆转心室重塑。

引用

页码：675 / 678

页数：4

共 8 条

[1]

Effect of combination angiotensin-converting enzyme and angiotensin receptor blocker therapy on heart failure mortality and morbidity [J].

Kapoor, John R. .

AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (05) :744-745

[2]

Inhibiting the renin–angiotensin system in myocardial infarction and heart failure: lessons from SAVE; VALIANT and CHARM; and other clinical trials.[J].Maria Tokmakova;Scott D Solomon.Current Opinion in Cardiology.2006, 4

[3]

Angiotensin-converting enzyme inhibitors and angiotensin II type I receptor blockers in the management of congestive heart failure patients: what have we learned from recent clinical trials? [J].

Mielniczuk, L ;

Stevenson, LW .

CURRENT OPINION IN CARDIOLOGY, 2005, 20 (04) :250-255

[4]

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:: Results from the Valsartan Heart Failure Trial (Val-HeFT) [J].

Maggioni, AP ;

Latini, R ;

Carson, PE ;

Singh, SN ;

Barlera, S ;

Glazer, R ;

Masson, S ;

Cerè, E ;

Tognoni, G ;

Cohn, JN .

AMERICAN HEART JOURNAL, 2005, 149 (03) :548-557

[5]

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction - Insight from the studies of left ventricular dysfunction (SOLVD) trials [J].

Vermes, E ;

Tardif, JC ;

Bourassa, MG ;

Racine, N ;

Levesque, S ;

White, M ;

Guerra, PG ;

Ducharme, A .

CIRCULATION, 2003, 107 (23) :2926-2931

[6]

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II [J].

Pitt, B ;

Poole-Wilson, PA ;

Segal, R ;

Martinez, FA ;

Dickstein, K ;

Camm, AJ ;

Konstam, MA ;

Riegger, G ;

Klinger, GH ;

Neaton, J ;

Sharma, D ;

Thiyagarajan, B .

LANCET, 2000, 355 (9215) :1582-1587

[7]

Angiotensin II receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failure [J].

Hamroff, G ;

Blaufarb, I ;

Mancini, D ;

Katz, SD ;

Bijou, R ;

Jondeau, G ;

Olivari, MT ;

Thomas, S ;

LeJemtel, TH .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 30 (04) :533-536

[8]

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure.[J].Allan D. Struthers.Journal of Cardiac Failure.1996, 1

← 1 →